Connecting Men, Families, Doctors, and other Medical Professionals to Clinical Trials for Prostate Cancer

        DISEASE CHARACTERISTICS:

          -  Diagnosis of cerebral metastases meeting the following criteria:

               -  One to three presumed brain metastases

               -  Metastases must be from a histologically confirmed extracerebral site (e.g.,
                  lung, breast, prostate)

                    -  Histologic confirmation may have been from the primary tumor site, from
                       another metastatic site (e.g., osseous metastasis, adrenal metastasis), or
                       from the metastatic brain lesion(s)

               -  Each lesion must measure less than 3.0 cm by contrast MRI of the brain performed
                  within the past 21 days

               -  Lesions must not be within 5 mm of the optic chiasm or within the brainstem

          -  Eligibility for treatment with gamma knife or linear accelerator-based radiosurgery
             confirmed by a radiation oncologist

          -  No primary germ cell tumor, small cell carcinoma, or lymphoma

          -  No leptomeningeal metastases

          -  Hormone receptor status not specified

        PATIENT CHARACTERISTICS:

          -  Male or female

          -  Menopausal status not specified

          -  ECOG performance status 0-2

          -  Not pregnant

          -  Negative pregnancy test

          -  Fertile patients must use effective contraception

               -  Male patients must continue to use contraception for 3 months after the
                  completion of radiotherapy

          -  No pacemaker or other MRI-incompatible metal in the body

          -  No known allergy to gadolinium

        PRIOR CONCURRENT THERAPY:

          -  More than 7 days since prior and no concurrent chemotherapy

          -  No prior cranial radiotherapy

          -  No prior resection of cerebral metastases

          -  Concurrent hormonal agents, steroids, and/or anticonvulsants allowed